Exercise training blunts microvascular rarefaction in the metabolic syndrome

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 291, Issue 5, 2006, Pages

  Frisbee, Jefferson C ^a   Samora, Julie Balch ^a   Peterson, Jonathan ^a   Bryner, Randall ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Microvessel density; Regulation of skeletal muscle perfusion; Skeletal muscle microcirculation; Vascular remodeling; Vascular resistance

Indexed keywords

CYTOKINE; GELATINASE A; GELATINASE B; NITRIC OXIDE;

ANGIOGENESIS; ANIMAL MODEL; ARTICLE; BODY MASS; EXERCISE; GASTROCNEMIUS MUSCLE; HYPEREMIA; INSULIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; MICROVASCULARIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; TREADMILL EXERCISE; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ARTERIOLES; BIOLOGICAL AVAILABILITY; BODY WEIGHT; CITRATE (SI)-SYNTHASE; CYTOKINES; FASTING; INSULIN; MALE; METABOLIC SYNDROME X; MICROCIRCULATION; MUSCLE, SKELETAL; NITRIC OXIDE; OBESITY; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, ZUCKER; TIME FACTORS; TRIGLYCERIDES; VASCULAR RESISTANCE;

EID: 33751196380     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00566.2006     Document Type: Article

References (54)

1. Arvola P, Wu X, Kahonen M, Makynen H, Riutta A, Mucha I, Solakivi T, Kainulainen H, and Porsti I. Exercise enhances vasorelaxation in experimental obesity associated hypertension. Cardiovasc Res 43: 992-1002, 1999.
2. Barbato JE, Zuckerbraun BS, Overhaus M, Raman KG, and Tzeng E. Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and the metabolic syndrome. Am J Physiol Heart Circ Physiol 289: H228-H236, 2005.
3. Becker-Zimmermann K, Berger M, Berchtold P, Gries FA, Herberg L, and Schwenen M. Treadmill training improves intravenous glucose tolerance and insulin sensitivity in fatty Zucker rats. Diabetologia 22: 468-474, 1982.
4. Bowles DK, Woodman CR, and Laughlin MH. Coronary smooth muscle and endothelial adaptations to exercise training. Exerc Sport Sci Rev 28: 57-62, 2000.
5. Bray GA. The Zucker-fatty rat: a review. Fed Proc 36: 148-153, 1977.
6. Chakraborti S, Mandal M, Das S, Mandal A, and Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253: 269-285, 2003.
7. Colombo M, Gregersen S, Kruhoeffer M, Agger A, Xiao J, Jeppesen PB, Orntoft T, Ploug T, Galbo H, and Hermansen K. Prevention of hyperglycemia in Zucker diabetic fatty rats by exercise training: effects on gene expression in insulin-sensitive tissues determined by high-density oligonucleotide microarray analysis. Metabolism 54: 1571-1581, 2005.
8. Dandona P, Aljada A, Chaudhuri A, Mohanty P, and Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111: 1448-1454, 2005.
9. Fan F, Stoeltzing O, Liu W, McCarty MF, Jung YD, Reinmuth N, and Ellis LM. Interleukin-1beta regulates angiopoietin-1 expression in human endothelial cells. Cancer Res 64: 3186-3190, 2004.
10. Ferreira I, Henry RM, Twisk JW, van Mechelen W, Kemper HC, and Stehouwer CD. Amsterdam Growth and Health Longitudinal Study. The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness: the Amsterdam Growth and Health Longitudinal Study. Arch Intern Med 165: 875-882, 2005.
11. Frisbee JC. Hypertension-independent microvascular rarefaction in the obese Zucker rat model of the metabolic syndrome. Microcirculation 12: 383-392, 2005.
12. Frisbee JC. Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 289: R307-R316, 2005.
13. Frisbee JC. Remodeling of the skeletal muscle microcirculation increases resistance to perfusion in obese Zucker rats. Am J Physiol Heart Circ Physiol 285: H104-H111, 2003.
14. Frisbee JC. Impaired skeletal muscle perfusion in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 285: R1124-R1134, 2003.
15. Fukushi J, Ono M, Morikawa W, Iwamoto Y, and Kuwano M. The activity of soluble VCAM-1 in angiogenesis stimulated by IL-4 and IL-13. J Immunol 165: 2818-2823, 2000.
16. Galinier A, Carriere A, Fernandez Y, Carpene C, Andre M, Caspar-Bauguil S, Thouvenot JP, Periquet B, Penicaud L, and Casteilla L. Adipose tissue proadipogenic redox changes in obesity. J Biol Chem 281: 12682-12687, 2006.
17. Garanty-Bogacka B, Syrenicz M, Syrenicz A, Gebala A, Lulka D, and Walczak M. Serum markers of inflammation and endothelial activation in children with obesity-related hypertension. Neuro Endocrinol Lett 26: 242-246, 2005.
18. Green DJ, Maiorana A, O'Driscoll G, and Taylor R. Effect of exercise training on endothelium-derived nitric oxide function in humans. J Physiol 561: 1-25, 2004.
19. Greene AS, Lombard JH, Cowley AW Jr, and Hansen-Smith FM. Microvessel changes in hypertension measured by Griffonia simplicifolia I lectin. Hypertension 15: 779-783, 1990.
20. Guerre-Millo M. Regulation of ob gene and overexpression in obesity. Biomed Pharmacother 51: 318-323, 1997.
21. Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 97: 3A-11A, 2006.
22. Henriksen EJ. Effects of acute exercise and exercise training on insulin resistance. J Appl Physiol 93: 788-796, 2002.
23. Herbert JM, Bernat A, and Chatenet-Duchene L. Effect of ciprofibrate on fibrinogen synthesis in vitro on hepatoma cells and in vivo in genetically obese Zucker rats. Blood Coagul Fibrinolysis 10: 239-244, 1999.
24. Hong KH, Ryu J, and Han KH. Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood 105: 1405-1407, 2005.
25. Hristova MA. Metabolic syndrome-neurotrophic hypothesis. Med Hypotheses 66: 545-549, 2006.
26. Izumi Y, Kim-Mitsuyama S, Yoshiyama M, Omura T, Shiota M, Matsuzawa A, Yukimura T, Murohara T, Takeya M, Ichijo H, Yoshikawa J, and Iwao H. Important role of apoptosis signal-regulating kinase 1 in ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol 25: 1877-1883, 2005.
27. Kim MY, Byeon CW, Hong KH, Han KH, and Jeong S. Inhibition of the angiogenesis by the MCP-1 (monocyte chemoattractant protein-1) binding peptide. FEBS Lett 579: 1597-1601, 2005.
28. Kingwell BA. Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease. FASEB J 14: 1685-1696, 2000.
29. Koh KK, Han SH, and Quon MJ. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. J Am Coll Cardiol 46: 1978-1985, 2005.
30. Kondo T, Kobayashi K, and Murohara T. Nitric oxide signaling during myocardial angiogenesis. Mol Cell Biochem 264: 25-34, 2004.
31. Kuroda T, Kitadai Y, Tanaka S, Yang X, Mukaida N, Yoshihara M, and Chayama K. Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment. Clin Cancer Res 11: 7629-7636, 2005.
32. Lee SY, Cho JY, Miller M, McElwain K, McElwain S, Sriramarao P, Raz E, and Broide DH. Immunostimulatory DNA inhibits allergeninduced peribronchial angiogenesis in mice. J Allergy Clin Immunol 117: 597-603, 2006.
33. Maruotti N, Cantatore FP, Crivellato E, Vacca A, and Ribatti D. Angiogenesis in rheumatoid arthritis. Histol Histopathol 21: 557-566, 2006.
34. Matsunaga T, Weihrauch DW, Moniz MC, Tessmer J, Warltier DC, and Chilian WM. Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide. Circulation 105: 2185-2191, 2002.
35. Matsunaga T, Warltier DW, Weihrauch DW, Moniz M, Tessmer J, and Chilian WM. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 102: 3098-3103, 2000.
36. Mayhan WG, Sun H, Mayhan JF, and Patel KP. Influence of exercise on dilatation of the basilar artery during diabetes mellitus. J Appl Physiol 96: 1730-1737, 2004.
37. McAllister RM, Jasperse JL, and Laughlin MH. Nonuniform effects of endurance exercise training on vasodilation in rat skeletal muscle. J Appl Physiol 98: 753-761, 2005.
38. Milkiewicz M, Ispanovic E, Doyle JL, and Haas TL. Regulators of angiogenesis and strategies for their therapeutic manipulation. Int J Biochem Cell Biol 38: 333-357, 2006.
39. Moller DE and Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 56: 45-62, 2005.
40. Nakao S, Kuwano T, Tsutsumi-Miyahara C, Ueda S, Kimura YN, Hamano S, Sonoda KH, Saijo Y, Nukiwa T, Strieter RM, Ishibashi T, Kuwano M, and Ono M. Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. J Clin Invest 115: 2979-2991, 2005.
41. Petersen AM and Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 98: 1154-1162, 2005.
42. Roberts CK and Barnard RJ. Effects of exercise and diet on chronic disease. J Appl Physiol 98: 3-30, 2005.
43. Ruel M, Song J, and Sellke FW. Protein-, gene-, and cell-based therapeutic angiogenesis for the treatment of myocardial ischemia. Mol Cell Biochem 264: 119-131, 2004.
44. Schmitz KH, Arnett DK, Bank A, Liao D, Evans GW, Evenson KR, Stevens J, Sorlie P, and Folsom AR. Arterial distensibility and physical activity in the ARIC study. Med Sci Sports Exerc 33: 2065-2071, 2001.
45. Spier SA, Delp MD, Meininger CJ, Donato AJ, Ramsey MW, and Muller-Delp JM. Effects of ageing and exercise training on endothelium-dependent vasodilatation and structure of rat skeletal muscle arterioles. J Physiol 556: 947-958, 2004.
46. Srere P. Citrate synthase. Methods Enzymol 13: 3-11, 1969.
47. Tan KH, De Cossart L, and Edwards PR. Exercise training and peripheral vascular disease. Br J Surg 87: 553-562, 2000.
48. Tanabe T, Maeda S, Miyauchi T, Iemitsu M, Takanashi M, Irukayama-Tomobe Y, Yokota T, Ohmori H, and Matsuda M. Exercise training improves ageing-induced decrease in eNOS expression of the aorta. Acta Physiol Scand 178: 3-10, 2003.
49. Troseid M, Lappegard KT, Claudi T, Damas JK, Morkrid L, Brendberg R, and Mollnes TE. Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome. Eur Heart J 25: 349-355, 2004.
50. Vaziri ND, Xu ZG, Shahkarami A, Huang KT, Rodriguez-Iturbe B, and Natarajan R. Role of AT-1 receptor in regulation of vascular MCP-1, IL-6, PAI-1, MAP kinase, and matrix expressions in obesity. Kidney Int 68: 2787-2793, 2005.
51. Walther C, Gielen S,Hambrecht R. The effect of exercise training on endothelial function in cardiovascular disease in humans. Exerc Sport Sci Rev 32:129 -134, 2004.
52. Xiang L, Naik J, and Hester RL. Exercise-induced increase in skeletal muscle vasodilatory responses in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 288: R987-R991, 2005.
53. Yu Y, Moulton KS, Khan MK, Vineberg S, Boye E, Davis VM, O'Donnell PE, Bischoff J, and Milstone DS. E-selectin is required for the antiangiogenic activity of endostatin. Proc Natl Acad Sci USA 101: 8005-8010, 2004.
54. Zheng H, Li YF, Cornish KG, Zucker IH, and Patel KP. Exercise training improves endogenous nitric oxide mechanisms within the paraventricular nucleus in rats with heart failure. Am J Physiol Heart Circ Physiol 288: H2332-H2341, 2005.